# Voyager Therapeutics, Inc.: Form 8-K, filed Jan 8, 2024

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2024-01-08
- Accepted by EDGAR: Jan 8, 2024, 16:49 ET
- Period: 2024-01-03
- Accession: 0001104659-24-002271
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000110465924002271/tm242314d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000110465924002271/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000110465924002271/tm242314d1_8k.htm

Filed Jan 8, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-002271. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.